Virus News and Research

Latest Virus News and Research

Respiratory syncytial virus affects the elderly and high-risk adults as much as influenza

Respiratory syncytial virus (RSV), primarily seen as a cause of illness in infants and children, often affects the elderly and high-risk adults as much as influenza, a study by University of Rochester Medical Center researchers demonstrates.

27 Apr 2005

Promising new West Nile therapy cures disease in mice

West Nile virus alarmed Americans when it made its first U.S. appearance in New York City in 1999. It has since spread from coast to coast, sickened more than 16,000 Americans and killed more than 600.

27 Apr 2005

HIV epidemic among young men unabated because many are unaware they are infected

U.S. health officials say many young gay and bisexual men who are HIV-positive are unaware they have the virus.

26 Apr 2005

Australian researchers develop West Nile virus treatment

A University of Queensland researcher has developed the world's first specific immunotherapy product using monoclonal antibodies for the potentially lethal West Nile virus, which causes seasonal epidemics around the globe.

26 Apr 2005

Generex Biotechnology receives Australian patent for vaccine technology to fight cancer and pandemic influenza

Generex Biotechnology announced today that its wholly owned subsidiary, Antigen Express, has received Australian Patent No. 778115 titled "Hybrid Peptides Modulate the Immune Response." Antigen Express is designing and testing such vaccine peptides for the control of cancer and infectious diseases with a particular focus on the pandemic H5N1 influenza, which has been reported in South East Asia.

26 Apr 2005

P12 protein influences key cell-signaling pathway

New research shows that a protein produced by a cancer-causing virus influences a key signaling pathway in the immune cells that the virus infects. This stimulates the cells to divide, helping the virus spread through the body.

26 Apr 2005

GenoMed launches free trial against Marburg virus epidemic in Angola

GenoMed announced today that it has launched a free clinical trial to combat the current Marburg virus epidemic in Angola.

26 Apr 2005

EU Commission provides further 1.5 million Euro to help tackle Marburg outbreak in Angola

The European Commission has approved a second emergency decision in response to the Marburg epidemic in northern Angola. The outbreak of this rare viral haemorrhagic fever has by now become the worst ever recorded of the disease. It is also the first time that cases have been diagnosed in an urban environment.

25 Apr 2005

Marburg outbreak appears to be under control at last

Medical teams attempting to control the worst outbreak ever recorded of the deadly Marburg virus in Angola are beginning to see the light at the end of the tunnel as cooperation from stricken communities improves, the U.N. health agency said.

25 Apr 2005

Antibody for West Nile virus shows promise

Researchers have developed an antibody that can cure mice of West Nile virus (WNV) infection, a disease for which no specific treatment exists, the National Institute of Allergy and Infectious Diseases (NIAID) has announced.

25 Apr 2005

Gene therapy for Alzheimer's disease shows promise

In the first clinical trial of gene therapy for Alzheimer's disease researchers have produced preliminary evidence that gene therapy may slow the decline in mental functioning associated with Alzheimer's disease.

25 Apr 2005

Birdflu outbreak in Korea contained

Drastic action which has included the culling of nearly 220,000 infected chickens, the vaccination of others and strict biosecurity measures, has successfully contained the recent outbreak of bird flu in the Democratic People’s Republic of Korea.

25 Apr 2005

H7 strain of the bird flu outbreak in North Korea contained

The recent outbreak of avian influenza in North Korea (DPRK) has been successfully contained, FAO said today, urging the country to continue surveillance on the affected farms and elsewhere to ensure that no residual infection remains.

25 Apr 2005

How Ebola virus infects cells - discovery

Ebola virus reproduction in laboratory-grown cells is severely hampered by enzyme-inhibiting chemicals, and these chemicals deserve further study as possible treatments for Ebola virus infections in humans, report scientists supported in part by the National Institute of Allergy and Infectious Diseases (NIAID).

23 Apr 2005

UK plan for influenza pandemic

The HPA Influenza Pandemic Contingency Plan outlines the Health Protection Agency’s plan for responding to an influenza pandemic. It replaces the Public Health Laboratory Service Pandemic Influenza Plan of July 2001.

23 Apr 2005

Almost all killer flu bug kits destroyed

99 percent of the kits containing a killer flu bug that mistakenly ended up in thousands of laboratories around the world, sparking fears of a pandemic, have been destroyed, according to top U.S. health official Dr. Julie Gerberding, director of the Centers for Disease Control and Prevention (CDC).

22 Apr 2005

Researchers make gains in understanding antibiotic resistance

Howard Hughes Medical Institute researchers chiseling away at the problem of antibiotic resistance now have a detailed explanation of how the drugs' main cellular target in bacteria evolves to become resistant to some of these medications.

22 Apr 2005

Discovery may lead to new drugs to prevent sexually transmitted HIV infection

Scientists have long suspected that HIV hijacks immune cells called dendritic cells to infiltrate the immune system. Now UCLA AIDS Institute researchers have shown that blocking HIV's access to a naturally occurring molecule on dendritic cells may cut their ability to smuggle the virus into other immune cells.

21 Apr 2005

Strongest evidence yet that infectious misformed proteins cause mad cow disease

Researchers at the University of Texas Medical Branch at Galveston (UTMB) have produced the strongest proof yet that the mysterious and devastating brain diseases known as "transmissible spongiform encephalopathies" (TSEs) are transmitted by an infectious agent composed only of a malformed protein, and not a virus.

21 Apr 2005